Author: NL.SWATHI

In response to a Right to Information (RTI) request, it was revealed that the Union Ministry of Health and Family Welfare has taken into account a long-standing request from the healthcare industry to establish standards for judging cases of medical negligence. The Ministry responded to a request made under the RTI Act on behalf of PTI by saying that although there isn’t a policy at the moment, the issue is being considered. “As of now, no rules have been established. According to Sunil Kumar Gupta, Under Secretary in charge of the Ministry’s medical education policy division, it is being taken…

The world’s largest producer of generic drugs, India is renowned for its low-cost generic drugs and vaccines. The Indian pharmaceutical industry has developed over time into a thriving industry, growing at a CAGR of 9.43% over the past nine years, and is currently ranked third in pharmaceutical production by volume.  Some of the key sectors of the Indian pharmaceutical industry include generic drugs, over-the-counter medicines, bulk drugs, vaccines, contract research & manufacturing, biosimilars, and biologics. Indian Markets India has 500 API producers, which accounts for about 8% of the global API market, and the most number of pharmaceutical manufacturing facilities…

The ISRO’s Gaganyaan Pilot and Apex Cover Separation parachutes have undergone deployment tests using the Rail Track Rocket Sled by the Indian Space Research Organization (ISRO). The Terminal Ballistics Research Laboratory (TBRL), Chandigarh, hosted the Rail Track Rocket Sled deployment tests on March 1 and 3. ISRO reported using the Gaganyaan Pilot and Apex Cover Separation parachutes in cluster configurations. ISRO continued by stating that the initial test mimicked the clustered deployment of two pilot parachute systems. The second parachute was subjected to a maximum angle with respect to flow conditions while the first parachute was subjected to a minimum…

On March 6, Prime Minister Narendra Modi said India is always working to ensure that its dependence on foreign nations for healthcare is kept to a minimum. He was speaking at a post-Budget webcast on health and medical research. PM Modi On India’s Healthcare On Monday, the Indian prime minister claimed that throughout the COVID-19 pandemic, life-saving tools like drugs, vaccines, and medical equipment were weaponized. He also argued that his administration has consistently worked to reduce India’s reliance on foreign nations for healthcare. According to him, the pre-and post-COVID era paradigm should be used to approach healthcare. During the…

In India, “approximately 1.5 million garbage collectors start the plastic recycling cycle.” Almost 41% of waste collectors’ revenues come from plastic. The income of rubbish pickers would reduce proportionately with any decrease in waste. Plastic Recycling Cycle Single-use plastic would become obsolete as soon as it was used. It comprises the majority of plastic waste, which is “all burned, buried in landfills, or thrown straight into the environment,” according to a study by the Australian group Minderoo Foundation. According to predictions, single-use plastics may account for 5–10% of all greenhouse gas emissions by the year 2050. Using marine algae, the…

The Texas Heart Institute’s physician-scientists have just released the findings of the biggest cell therapy trial yet conducted on patients with persistent heart failure brought on by low ejection fraction. Patients benefited from the treatment by having their ejection fraction measured as having a stronger heart and by having a lower risk of heart attack or stroke, especially in those with high levels of inflammation. Also, a significant signal was discovered in the decline in cardiovascular death in individuals receiving cell therapy. For the first time, Mesoblast Inc.’s MPC (mesenchymal precursor cells), an immunomodulatory cell type, may address inflammation, a…

Elon Musk has frequently disagreed with the authorities in charge of securities regulation and road safety, but there is one area the Tesla and Twitter founder believes the government should now regulate: artificial intelligence. Musk stated, “AI stresses me out,” toward the end of a more than three-hour presentation to Tesla investors about company plans. The third in a series of papers on how to grow Tesla and transition the world to clean energy, Musk’s “Master Plan 3,” featured Tesla’s own ambitious artificial intelligence efforts.A video showed a Tesla Optimus humanoid robot manipulating components from other Optimus robots as if…

Pseudomonas aeruginosa is the target of the treatment because it is a common cause of infections in hospitals and is a type of bacteria that is naturally resistant to many different antibiotics.  The first “living medicine” to treat lung infections has been created by researchers. To treat the condition, a strain of the bacterium Mycoplasma pneumonia that has been altered to attack P. aeruginosa rather than cause disease is used. Low doses of antibiotics that would not otherwise be effective alone are combined with the modified bacteria. Researchers examined the treatment’s effectiveness in mice and discovered that it significantly decreased…

Inadequate funding for care and the widespread use of harmful substances and medications are the main causes of the nation’s declining vulture population. The population of vultures, which are natural scavengers, has declined. The ecosystem benefits from vultures because they stop epidemics from spreading. Without it, the population of feral dogs grows and they start to spread various diseases that can affect people, animals, and livestock. The Bombay Natural History Society (BNHS) recently requested in writing to the Union Ministry of Environment, Forest and Climate Change (MoEF&CC) that the use of three veterinary medications that are known to kill vultures…

AbbVie announced today that U-EXCEED achieved positive top-line results. The U-EXCEED study is divided into three parts. The first phase is a 12-week placebo-controlled induction period. Part 2 of U-EXCEED is an open-label arm that evaluated an additional group of patients who received upadacitinib 45 mg for 12 weeks. At week 12, upadacitinib (45 mg once daily) achieved both primary endpoints of clinical remission and endoscopic response in a Phase 3 induction study. Patients with moderate-to-severe Crohn’s disease who had an inadequate response or were intolerant to biologic therapy were enrolled in the U-EXCEED study, with more than 60% having…